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SUPPLEMENTAL MATERIALS 
 
S1.  Scale up from 10 nL chip-based FID Crystallization Screens
The screening of various kinetic trajectories was tested by exporting successful nanoliter-
volume µFID crystallization conditions to 125 nL reactors on the optimization chip.  The 
osmotic bath and permeation barrier protocols were evaluated in scaling up the 
crystallization of a total of 14 targets including 8 well-characterized crystallization 
standards (chicken egg white lysosyme (LYS), ferritin (FER), glucose isomerase (GI), 
bovine liver catalase (CAT), recombinant human insulin (INS), xylanase (XYL), 
alphalactalbumin (ALPH), and thaumatin (THM), three previously crystallized integral 
membrane proteins (the mechanosensitive ion channel of large conductance (MSCL) from 
E. coli, bacteriorhodopsin from the archeaon Halobacterium NRC-1 (BOP), and a BOP 
point mutant (BOP D85S)), one nucleic acid/protein complex known to require precise 
crystallization conditions in hanging drop (the E. coli Rho transcription termination factor 
with r(CU)4 RNA and AMPPNP (Rho)), and two targets of unknown structure that had 
been crystallized only in µFID format (the transferrin receptor heterodimer complexed with 
HFE (hdTFR/HFE), and a mutant P450 alkane hydroxylase (BM3 1-12G)).  In all trials, 
protein samples were equilibrated by free interface diffusion against a successful 
crystallization agent whose identity was determined by prior µFID screening on chip. 
Simultaneously, the rate and extent of vapor transport were screened across the twenty 
reactors by varying the concentration of the osmotic bath solution or the thickness of 
permeable oil layer.  
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The permeation barrier protocol was successful in improving crystal morphology and 
increasing crystal size for of all 14 targets tested.  This success, which occurred despite the 
highly varied sample pool, establishes this approach as a high correspondence method for 
scaling up nanoliter volume crystallization.  In contrast, the osmotic bath protocol was 
successful in scaling up crystallization conditions for only five of the ten targets, including 
all eight model proteins, BOP, BOP D85S, and MSCL.  In particular, multiple subsequent 
trials using hdTFR/HFE, Rho and P450 1-12G failed to produce crystals despite extensive 
screening of the final reaction state.  This lack of correspondence may be due either to 
insufficient concentration of the osmotic bath solutions or to transient osmotic differences 
between the sample and the reagent wells, leading to unwanted convection between the 
wells.  In the later case this behavior can be avoided by using a permeation barrier protocol 
during the transient FID stage, followed by an osmotic bath protocol for longer times.  
 
S2.  Crystal Growth Conditions  
Crystals of ferritin (type 1 from horse spleen; Sigma Aldrich Company) were grown by 
FID diffusion at 4 °C of 2 parts protein stock (34 mg/mL ferritin, 150 mM sodium 
chloride) against 1 part crystallization agent (1 M sodium acetate, 50 mM cadmium sulfate, 
100 mM HEPES·HCl, pH 7.5) with an osmotic bath solution consisting of 50 % 
crystallization agent.  Crystals of insulin (human recombinant; Sigma Aldrich Company) 
were grown by FID diffusion at 25 °C of 1 part protein stock (10 mg/mL insulin, 25 mM 
HEPES·HCl, pH 8.2) against 1 part crystallization agent (30% v/v MPD, 200 mM 
magnesium acetate, 100 mM sodium cacodylate, pH 6.5) with an osmotic bath solution of 
75% crystallization agent.  Crystals of lysozyme (chicken egg white; Sigma Aldrich 
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Company) were grown by FID diffusion at 25 °C of 2 parts protein stock (85 mg/mL 
lysozyme, 100 mM sodium chloride, 100 mM sodium acetate, pH 4.5) against 1 part 
crystallization agent (4 M sodium chloride, 100 mM sodium acetate pH 5.2) with a 
reservoir solution of 140 µL of fluorinated silicone oil (poly-3,3,3-Trifluoropropyl-
methylsiloxane; Hampton Research).  Crystals of catalase (bovine liver; Sigma Aldrich 
Company) were grown by counter diffusion of 1 part protein stock (15 mg/mL catalase) 
against 1 part crystallization agent (25% v/v PEG 2000 MME, 100 mM potassium sulfate, 
100 mM TRIS·HCl pH 8.5) over a period of 7 days with varying connecting channel 
lengths and osmotic bath strengths (% of crystallization agent). 
 
S3.  In Situ Diffraction Studies  
       A. Harvesting crystals for in situ diffraction studies 
Sections of elastomer membrane containing protein crystals were excised from the chip and 
mounted for diffraction studies in situ both at room and cryogenic temperatures.  For room 
temperature mounts, a 3/8” punch tool (Technical Innovations; Brazoria, TX) was inserted 
through the open face of the reagent reservoirs and used to cut around the periphery of the 
membrane, creating a thin PDMS disk containing the protein crystals.  Membranes were 
harvested from selected reactors without disturbing adjacent reactions.  Disks were 
sectioned into 1 mm thick strips and mounted on a standard magnetic “crystal cap” 
(Hampton Research; Aliso Viejo, CA) fitted with a small alligator clip as shown in Figure 
3a of main text.  In cases where the screening of a large number of crystals grown from 
identical conditions was desired the entire crystal disk was mounted without sectioning 
(Figure S1a). For diffraction studies at cryogenic temperatures, a variety of cryoprotectant 
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solutions were slowly introduced to the microwells containing crystals by diffusion across 
the connecting microchannel.  At each reaction site the osmotic bath solution was replaced 
with a solution containing the appropriate concentration of crystallization agent and a cryo-
protectant.  The membrane covering microwell opposite to the crystals was then perforated 
using a microknife (Hampton Research), and the cryoprotectant was allowed to slowly 
diffuse into the crystal wells over a period of 1 to 3 days.  Sections of membrane containing 
crystals were then harvested as described above and frozen by immersion in liquid 
nitrogen.   
 
B. Crystal Alignment 
Sections of PDMS membrane containing protein crystals were excised using a punch and 
mounted using standard crystal caps (Hampton Research) fitted with a 1 cm long alligator 
clip (Figure S1a).  In addition to providing minimal x-ray attenuation, the short optical path 
through the PDMS membrane facilitates crystal alignment without significant errors due to 
optical aberrations or parallax despite the high index contrast (nPDMS = 1.4).  The excellent 
optical properties of the PDMS membrane are demonstrated in Figure S1b which shows the 
localized bleaching of a crystal of BOP precisely aligned to a pre-focused X-ray beam 
having a diameter of 30 microns. 
 
C.  In Situ Cryogenic Freezing 
 
Suppressing microcrystalline ice formation requires rapid freezing so that vitrification 
occurs and nucleation is prevented.  Despite the high surface to volume ratio and low 
thermal mass (~ 0.75 mJ / K) of the PDMS membrane strips, we were concerned that the 
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low thermal conductivity of the polymer (0.15 W / m K) may adversely affect freezing.   
To investigate this possibility, we measured the minimum concentration of cryoprotectant 
necessary for freezing a solution so as to form an amorphous glass.  Diffraction patterns of 
frozen PDMS membranes filled with varying concentrations of glycerol ranging from 20 to 
40 % (v/v) were analyzed to determine the minimum concentration required to suppress the 
formation of microcrystalline ice in frozen PDMS membranes.  A sharp transition from a 
pronounced ice ring (top of Figure S1d) to a diffuse solvent ring (bottom of Figure S1d) 
was observed between 28 % and 30 % glycerol, corresponding to a minimum concentration 
of 29 ± 1 %.  This value is very close to the minimum concentration of 27 ± 1 % 
determined for vitreous flash-freezing in a conventional 200 micron diameter nylon loop, 
indicating that heat transfer through the PDMS membranes is efficient. 
 
D. Room Temperature Studies 
Chip-grown crystals of lysozyme and MSCL were harvested for diffraction studies in situ 
at room temperature as described (methods).  In this format the PDMS membrane protects 
crystals from the ambient conditions, avoiding rapid dehydration.  Crystals of MSCL 
harvested by this method were stable for over an hour and showed no signs of 
deterioration, providing ample time for preliminary analysis on a home X-ray source. 
Room temperature diffraction studies were performed using a Rigaku RU200 generator and 
R-AXIS IV detector.  One degree oscillation frames of lysozyme crystals taken at normal 
incidence through 250 µm PDMS disks, showed strong reflections to approximately 1.6 Ǻ 
(Figure S1c), which was the limit of our detector.  In addition to the usual solvent ring at 
3.5 – 3.8 Å, diffuse scatter from the PDMS was visible as a powder ring at approximately 7 
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Å (Figure S1d, bottom).  MSCL crystals diffracted much more weakly, with the highest 
angle reflections visible at approximately 12 Å.  This weak diffraction was consistent with 
that obtained from crystals that were mounted and frozen in standard cryo-loops.  The low 
resolution diffraction from MSCL crystals grown in this condition was used to quickly 
reveal the poor order intrinsic to this crystal form under native conditions and eliminated 
the need to attempt further optimization of freezing conditions. 
 
E.  X-ray Absorption of PDMS Membranes  
The linear absorption coefficient of PDMS at X-ray energies of 8.05 KeV (corresponding 
to the Cu-α line) is approximately µ = 24.4 cm-1 which is slightly less than that of 
borosilicate glass (µ = 30.0 cm-1).  For a 50 µm thick membrane this corresponds to a 
transmission factor of approximately 88%.  At 11 KeV, an energy commonly used at 
synchrotron sources, the linear absorption coefficient of PDMS is reduced to approximately 
7 cm-1, corresponding to a transmission coefficient of approximately 97% for a 50 µm 
membrane.   
 
The rectangular cross-section of the PDMS membranes results anisotropic X-ray absorption 
and background scatter during data collection (Figure S2a).  This increased background 
scatter and attenuation due to the PDMS does affect the signal-to-noise ratio of the data as a 
function of membrane angle (Figure S2b).  The mean I/σ passes through a minimum at 
approximately 80° due to the finite width and rectangular shape of the membrane, reducing 
the signal to noise by a factor of approximately three.   We estimate that useful diffraction 
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data may be collected from crystals grown in the current format over an angle of 120°, 
which is sufficient for data collection on all but triclinic and monoclinic space groups.   
 
  F. Data collection, structure determination, and refinement 
Data were collected at Beamline 12.3.1 at the Advanced Light Source 1 and processed 
using ELVES 2 and DENZO/SCALEPACK 3.  All MR solutions were built and refined 
using hands-off, fully automated procedures. Greater than 94% of the residues were 
correctly placed in all four structures and refined to an R-free value of 23% or without 
manual rebuilding (Supplemental Table 1). Molecular replacement (MR) was performed 
with Phaser 4,5 using poly-alanine or poly-glycine models generated from the following 
starting models: 1HEQ (lysozyme) 6, 1KWN (thaumatin) 7, 1CAT (catalase) 8, 6XIA 
(glucose isomerase) 9. MR solutions were subjected to 8 rounds of fully automated protein 
model building and structure refinement using ARP/wARP 10 and REFMAC5 11. Electron 
density maps and refined models were inspected in O 12. 
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S4.  In Situ Diffraction Data and Phasing Statistics  
Table 1.  Data collection and phasing and refinement statistics for diffraction studies in 
situ. 
 
 
Crystallographic and Refinement Statistics 
 
Lysozyme Thaumatin Catalase 
Glucose 
Isomerase 
Thaumatin 
(home 
source) 
A. Data Collection      
Space Group P43212 P41212 P3221 I222 P41212 
Resolution (Ǻ) 50 – 1.2 50 – 1.25 50 – 1.9 50 – 1.3 50 - 1.7 
Unit Cell       
A  (Ǻ) 78.9 57.7 139.4 102.6 57.8 
b  (Ǻ) 78.9 57.7 139.4 93.0 57.8 
C  (Ǻ) 36.9 148.8 97.4 98.0 150.3 
α β γ (°) 90 90 90 90 90 90 90 90 120 90 90 90 90 90 90 
X-ray source ALS 12.3.1 ALS 12.3.1 ALS 12.3.1 ALS 12.3.1 RAXIS-IV 
Wavelength (Ǻ) 1.13 1.127 1.127 1.116 1.542 
Data collected (°) 60 80 30 100 47 
Total reflections 191974 336451 218595 783377 363748 
Unique reflections 36938 68255 86050 111486 26212 
Multiplicity 4.7 3.2 2.5 3.7 3.2 
Completeness (%) 84.8 (76.3) 91.5 (92.4) 70.3 (59) 97 (82.3) 90.6(43) 
Wilson B-factor 10 12 18 13 20 
Mosaicity (°) 0.08 0.06 0.1 0.2 0.5 
Rsym (%)  4.7 (22.6) 6.6 (40.2) 6.9 (34) 8.2 (39.7) 4.2(20.1) 
I/σ 9.6 (2.8) 2.4 (1.4) 8.7 (2.0) 3.6 (1.8) 23.3(2.1) 
Crystal Volume 
(µm3 x 1000)  
3375 6000 640 1720 12000 
 
B. Phasing & Refinement 
MR search model 1HEQ-polyG 1KWN-polyA 1CAT-polyG 6XIA-polyA 1KWN-polyG
MR program Phaser Phaser Phaser Phaser Phaser 
      
    8 rounds of ARP/wARP auto building with subsequent REFMAC5 refinement 
Residues built 121/129 197/207 970/1012 384/387 200/207 
Observation to 
Parameter ratio 
6.16 8.86 1.87 8.71 3.87 
Rcryst (%) 20.8 20.5 21.3 19.1 19.8 
Rfree (%) 23.9 23.0 28.6 21.0 22.9 
      
a Rsym = Σhkl|I(hkl)-〈I(hkl)〉 |/Σ 〈I(hkl)〉, where I(hkl) and 〈I(hkl)〉 are the measured and average intensities of 
multiple measurements  of the same reflection. 
b Rcryst (Rfree) = Σhkl||Fobs(hkl) |-|Fcalc(hkl) | |/Σ|Fobs(hkl) |, where Fobs and Fcalc are the observed and calculated 
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structure factor amplitudes. 
c Rfree was calculated using 5% of reflections not used during refinement. 
Values in parentheses represent data in highest resolution shell. 
 
S5.  Device Fabrication 
The microfluidic device used for kinetic optimization of protein crystallization and in situ 
diffraction studies is shown in figure S3. 
Devices were fabricated using the technique of Multilayer Soft Lithography by 
consecutive replica molding of planar elastomer structures from microfabricated molds 
and bonding 13,14.  
1. Mold Fabrication.  Three molds used for replica micro-molding of the flow structure, 
control structure and fluid reservoirs were fabricated on 3” silicon wafers using standard 
photolithography procedures.   
Reservoir molds were fabricated having circular patterns for alignment and punching of 
osmotic bath reservoirs as described in the MSL fabrication protocol below.  Details of 
photoresist processing are provided below.     
 
I. Reservoir Molds   
 
Spin SU8 2025:  3000 rpm x 45 s / 15 second ramp up  
     film thickness = 13 microns 
 
Pre-Exposure Bake: contact bake hotplate 
    1 min x 65 C / 5 min x 95 C 
 
Expose Wafer:  define reservoirs 
    25 s at 7 mW/cm2 
 
Post-Exposure Bake: 1 min x 65 C / 5 min x 95 C 
 
Develop:   100 % Shipley Nanodeveloper 
    rinse with fresh developer 
    dry under nitrogen 
  
 
Multilevel flow molds defining the FID reactors and connecting channels were fabricated 
using a two-step lithography process.  16 micron high flow channels were first patterned 
using a positive resist, reflowed to create a rounded flow-channel cross-section, and hard-
baked to withstand further processing.  A 150 micron thick layer of negative resist was 
then applied over this structure and patterned to form the reaction chambers.  Details of 
photoresist processing are provided below.    
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II. Flow Mold  
 
Priming:   HDMS vapor 1 min in tuperware container (STP) 
 
Spin 5740:   900 rpm x 50 s / 5 s ramp 
    Film thickness = 16 microns 
 
Soft Bake:   contact bake hotplate 
    110 C x 100 s 
 
Expose Wafer:  define channel structure 
    70 at 7 mW/cm2 
 
Develop:   7:1 dilution of Shipley 2401 developer 
    rinse DI H2O  
    dry under nitrogen 
 
Reflow:   contact hotplate 
    115 C x 25 min 
 
Hard Bake:  in oven  
    ramp 120 C to 180 C 
    hold 1 hr 
    ramp 180 C to 120 C 
 
Spin SU8 100:  1500 rpm x 60 s / 15 s ramp  
    Film thickness = 150 microns 
    sit for 15 minutes on flat level surface 
 
Pre-Exposure Bake: contact bake on level hotplate 
    5 min x 65 C / 30 min x 95 C / 1 min 65 C 
    cool to room temperature 
 
Expose Wafer:  define microwells and high i/o   
130 s at 7 mW/cm2 
 
Post-Exposure Bake:  2 min x 65 C / 12 min x 95 C / 1 min x 65 C 
 
Develop:   100 % Shipley Nanodeveloper 
    rinse with fresh developer 
    dry under nitrogen 
 
Control molds defining the valve structures were fabricated from a single 25 micron thick 
layer of negative photoresist as described below.  
 
III. Control Mold 
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Spin SU8 2025:  3000 rpm x 45 s / 15 second ramp up  
     film thickness = 13 microns 
 
Pre-Exposure Bake: contact bake hotplate 
    1 min x 65 C / 5 min x 95 C 
 
Expose Wafer:  define control structure 
    25 s at 7 mW/cm2 
 
Post-Exposure Bake: 1 min x 65 C / 5 min x 95 C 
 
Develop:   100 % Shipley Nanodeveloper 
    rinse with fresh developer 
    dry under nitrogen 
 
Hard Bake:  contact hotplate 
150 C x 60 min 
 
MSL Fabrication 
 
Replica molding and bonding steps are detailed below. 
 
Priming:   all molds were treated with  
    Trimethylchlorosilane (TMCS) vapor for 5 min 
(STP) 
 
Cast Reservoir Layer: 36 grams of silicone elastomer (GE 615 RTV) was 
combinded at a 5:1 ratio (36 g A: 7 g B) and poured 
onto reservoir mold (thickness ~ 7.5 mm) 
 
Degas Reservoir Layer: Reservoir mold was subject to vacuum (~90 Torr) 
for 30 minutes 
 
Spin Flow Layer 1: A 180 micron thick layer of 5:1 (A:B) GE 615 RTV  
was applied to the flow mold by spin coating at 350 
rpm for 60 s. 
 
Degas Flow Layer: Reservoir mold was subject to vacuum (~90 Torr) 
for 10 minutes 
 
Spin Control Layer: A 28 micron thick layer of 20:1 (A: B) GE 615 
RTV was applied to the control mold by spin 
coating at 1800 rpm for 60 s. 
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Spin Blank Layer: A 30 micron thick layer of 20:1 (A: B) GE 615 
RTV was applied to an unpatterned 3” silicon wafer 
by spin coating at 2000 rpm for 60 s. 
 
1st Cure Reservoir Layer: The reservoir mold was cured at 80 C for 80 
minutes in a convection oven 
 
1st Cure Flow Layer: The flow mold was cured at 80 C for 60 minutes in 
a convection oven 
 
Spin Flow Layer 2: A 30 micron thick layer of 20:1 (A: B) GE 615 
RTV was applied to the control mold by spin 
coating at 2000 rpm for 60 s. 
 
2nd Cure Control Layer: The flow mold was cured at 80 C for 20 minutes in 
a convection oven 
 
Punching Reservoirs: The reservoir layer was released from the mold and 
reservoirs were punched using a 3/8” punch tool.  
 
Reservoir/Flow Bonding: The reservoir layer was aligned to the flow layer 
and baked at 80 C for 60 minutes to bond the layers. 
 
1st Cure Control Layer: The control layer was cured at 80 C for 40 minutes 
in a convection oven. 
 
Control/Flow Bonding: The bonded flow and reservoir layers were peeled 
from the flow mold and aligned to the control layer.  
The three layers were then cured at 80 C for 70 
minutes to bond the flow and control layers. 
 
1st Cure Blank Layer: The blank layer was cured at 80 C for 40 minutes in 
a convection oven. 
 
Puncing I/O Ports: The bonded control, flow, and reservoir layers were 
peeled from the control mold and input flow and 
control ports were punched.  
 
Blank/Control Bonding:   The bonded layers were placed on the blank layer 
and cured at 80 C for 12 hours to seal the device. 
 
Dicing: The finished device was peeled from the 
unpatterned silicon wafer, cut to size, and mounted 
on a microscope slide. 
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 Supplementary Figures 
 
 
Figure S1.  In situ diffraction studies of crystals grown in semi-permeable elastomer 
membranes.  a.  Membrane disk of PDMS mounted on a modified crystal cap in situ.  b.  
Optical micrograph showing the alignment of crystals of BOP for x-ray analysis.  The 
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crystal on the right is being irradiated with a 30 µm diameter x-ray beam focused at the 
white circle.  Proper alignment of the beam with the crystal is apparent from the localized 
discoloration due to x-ray photo-bleaching.  c.  High resolution diffraction pattern of a 
lysozyme crystal mounted in a PDMS membrane.  Image was taken on a home source (R-
AXIS IV; Rigaku) with 1° oscillation and 15 minute exposure using a copper anode 
generator (λ = 1.542 Ǻ).  Inset shows clear reflections at 1.6 Ǻ which was the limit of the 
detector.  d.  Diffraction patterns of PDMS membranes showing the freezing transition 
from microcrystalline ice formation at 28 % v/v glycerol (top) to amorphous glass at 30% 
v/v glycerol (bottom).  The sharp ring at approximately 3.7 Ǻ indicates microcrystalline ice 
formation in the top image.  A diffuse powder diffraction ring from the PDMS membrane 
is visible at approximately 7 Ǻ in both images.  Images were taken as in (c) with 2 minute 
exposure. 
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Figure S2. Anisotropy in X-ray scatter and absorption.  a.  Home source (R-AXIS IV; 
Rigaku) oscillation image of diffraction pattern with x-rays incident 45° from normal 
showing anisotropic background scatter and reflection intensities.  Image was taken at 100 
K with 1° oscillation and 15 minute exposure at a detector distance of 250 mm.  b.  Plot of 
I/σ as a function of angle of x-ray incidence from normal to membrane for resolution bands 
from 20 Å to 2 Å.  Each point represents a 5° moving average of I/σ values determined 
from 1° oscillations.  Data were collected on a home source (R-AXIS IV; Rigaku) with 20 
minute exposures and detector distance of 150 mm from a single thaumatin crystal.   
 
 
 
Figure S3.  Microfluidic device for protein crystal growth by combined free interface and 
membrane-mediated vapor diffusion in semi-permeable elastomer membranes.  a.  
Photograph of microfluidic device mounted on a 2” x 3 ½” microscope slide showing the 
3/8” circular wells that comprise 20 independent reaction sites.  b.   Schematic showing 
layout of device channels (blue) and valve structures (red).  Two reagent inlets (blue dots) 
permit loading of a concentrated protein solution and a single crystallization solution.  A 
microfluidic channel structure simultaneously distributes each solution to distinct reaction 
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sites (black circles) each containing five separate FID reactors.  The entire array of reaction 
sites consists of five columns that contain protein solution to crystallization solution mixing 
ratios of 3:1, 2:1, 1:1, 1:2, and 1:3, and four rows with different diffusion channel lengths 
(300, 600, 1200, and 2400 µm).       
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